No link between early childhood cancers and living near mobile phone base station during pregnancy, says study

June 22, 2010

No link between early childhood cancers and living near mobile phone base station during pregnancy, says study

A new study looking at the patterns of early childhood cancers across Great Britain has found no association between a mother living near to a mobile phone base station during her pregnancy and the risk of that child developing cancer before reaching the age of five.

The study, published today on bmj.com, is the first to look at the health effects of mobile phone base stations in Great Britain as a whole, and is the largest of its kind.

Use of mobile (cellular) phones has increased markedly in recent years and questions have been raised about possible health effects, including brain and other cancers, especially after prolonged use.

Opinion surveys also indicate high levels of public concern about the potential risks of living near mobile phone base stations.

Previous reports of apparent cancer clusters near mobile phone base stations are difficult to interpret, due to small numbers and possible biases that could have affected the results. There is also a lack of any radiobiological explanation for such cancer excesses.

For today's study, researchers from Imperial College London looked at almost 7,000 children and explored whether there was any correlation between a mother living near a mobile phone base station during her pregnancy and that child's risk of developing cancer.

The researchers identified 1,397 British children aged 0-4 years, who were registered with leukaemia or a tumour in the brain or central nervous system between 1999 and 2001.

The researchers compared data on how close the children's birth addresses were to a mobile phone base station, with the same data on children selected as controls. For each child with cancer, four healthy children who shared the same gender and birth date were chosen at random to act as controls.

They were unable to take account of the proportion of mothers who might have moved to the birth address from another address during their pregnancy, because these data were unavailable.

The researchers analysed the approximate distance (in metres) between the birth address and the nearest mobile phone base station, the total power output for base stations within 700m of the birth address, and the power density for base stations within 1400m of the birth address.

They used this information to compare estimates of the mothers' radio frequency exposures from mobile phone base stations over nine months of pregnancy.

The patterns that they identified revealed that the children with cancer are no more likely to have a birth address near a base station than those who do not have cancer. The estimated radio frequency exposures to mobile phone base stations were similar for the mothers of children with cancer and the children acting as controls.

Professor Paul Elliott, Director of the MRC-HPA Centre for Environment and Health at Imperial College London, who is the corresponding author of the study, said: "People are worried that living near a mobile phone mast might affect their children's health. We looked at this question with respect to risk of cancers in young children. We found no pattern to suggest that the children of mums living near a base station during pregnancy had a greater risk of developing cancer than those who lived elsewhere."

The researchers point out that there are a number of aspects of childhood cancer and exposure to mobile phone base stations that this study was not able to investigate. They would like to analyse whether there is any association between children's own exposure to mobile phone base stations and their risk of developing cancer - for today's study, complete data were only available on the children's birth addresses and not the addresses where they might subsequently have moved to. Also, the mothers' and children's details were identified from national registers and the researchers did not have individual contact with them.
-end-
Today's study was funded by the Mobile Telecommunications and Health Research (MTHR) Programme.

Professor Elliott is Principal Investigator for the UK arm of the cohort study on mobile communications (COSMOS), which launched in April 2010, which is also part of the MTHR Programme. This international study will run for 20-30 years and will follow the health of around 250,000 participants aged 18-69 in five European countries.

Imperial College London

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.